{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:47:43Z","timestamp":1763016463861},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.ijantimicag.2003.07.020","type":"journal-article","created":{"date-parts":[[2004,2,10]],"date-time":"2004-02-10T10:17:53Z","timestamp":1076408273000},"page":"273-285","source":"Crossref","is-referenced-by-count":66,"title":["Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi"],"prefix":"10.1016","volume":"23","author":[{"given":"Luciana R.","family":"Garzoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aura","family":"Caldera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria de Nazareth L.","family":"Meirelles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange L.de","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Docampo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary A.","family":"Meints","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Oldfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio A.","family":"Urbina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB1","unstructured":"World Health Organisation. Control of Chagas disease. Tech Rep Ser 905;2002:1\u2013109."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB2","unstructured":"Dias JCP. Epidemiologia. In: Brener Z, Andrade Z, Barral-Netto C, editors. Trypanosoma cruzi e doen\u00e7a de Chagas. Rio de Janeiro: Guanabara Koogan; 1999. p. 48\u201374."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1381612023396177","article-title":"Chemotherapy of Chagas disease","volume":"8","author":"Urbina","year":"2002","journal-title":"Curr Pharma Des"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S0074-02762002000100001","article-title":"A critical review on Chagas disease chemotherapy","volume":"97","author":"Coura","year":"2002","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB5","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/1381612013397546","article-title":"Recent developments in the chemotherapy of Chagas disease","volume":"7","author":"Docampo","year":"2001","journal-title":"Curr Pharma Des"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2174\/1381612013397555","article-title":"Specific molecular targets to control tropical diseases","volume":"7","author":"Rodriguez","year":"2001","journal-title":"Curr Pharma Des"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1006\/bbrc.1999.1404","article-title":"Nitrogen-containing bisphosphonates as carbocation transition state analogs for isoprenoid biosynthesis","volume":"263","author":"Martin","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/abbi.1999.1502","article-title":"Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase","volume":"373","author":"Bergstrom","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/pest.1999.2397","article-title":"The discovery of a novel site of action for herbicidal bisphosphonates","volume":"63","author":"Cromartie","year":"1999","journal-title":"Pest. Biochem Physiol"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1359\/jbmr.2000.15.5.971","article-title":"The intracellular target of the antiresorptive aminobisphosphonate drugs in Dictyostelium discoideum is the enzyme farnesyl diphosphate synthase","volume":"15","author":"Grove","year":"2000","journal-title":"J Bone Mineral Res"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/bbrc.1999.0224","article-title":"Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase\/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their anti-resorptive potencies in vitro and in vivo","volume":"251","author":"van Beek","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/bbrc.1999.1499","article-title":"Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates","volume":"264","author":"van Beek","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB13","doi-asserted-by":"crossref","first-page":"33930","DOI":"10.1074\/jbc.M103950200","article-title":"Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase","volume":"276","author":"Montalvetti","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-6851(01)00246-8","article-title":"The acidocalcisome","volume":"33","author":"Docampo","year":"2001","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1568005013343191","article-title":"Bisphosphonates as chemotherapeutic agents against trypanosomatids and Apicomplexan parasites","volume":"1","author":"Docampo","year":"2001","journal-title":"Curr Drug Targets-Infect Dis"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/jm0002578","article-title":"Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii and Plasmodium falciparum: a potential route to chemotherapy","volume":"44","author":"Martin","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB17","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1021\/jm0102809","article-title":"Activity of bisphosphonates against Trypanosoma brucei rhodesiense","volume":"45","author":"Martin","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1086\/341074","article-title":"Radical cure of experimental cutaneous leishmaniasis by the bisphosphonate pamidronate","volume":"186","author":"Rodriguez","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0960-894X(01)00057-9","article-title":"Bisphosphonates derived from fatty acids are potent growth inhibitors of Trypanosoma cruzi","volume":"11","author":"Szajnman","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1128\/AAC.46.3.929-931.2002","article-title":"In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii","volume":"46","author":"Yardley","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archinte.161.3.353","article-title":"Risedronate: a clinical review","volume":"161","author":"Crandall","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB22","first-page":"191","article-title":"Sobre uma cepa de Trypanosoma cruzi virulenta para o camundongo branco","volume":"20","author":"Silva","year":"1953","journal-title":"Folia Clinica Biologica"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB23","first-page":"136","article-title":"Trypanosoma (Schizotrypanum) cruzi: terminal oxidases in exponential and stationary growth phase epimastigotes cultured in vitro","volume":"35","author":"De Maio","year":"1984","journal-title":"Acta Cientifica Venezolana"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB24","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0035-9203(83)90176-1","article-title":"Suggested guidelines for work with live Trypanosoma cruzi","volume":"77","author":"Hudson","year":"1983","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB25","first-page":"198","article-title":"Interaction of Trypanosoma cruzi with heart muscle cells: Ultrastructural and cytochemical analysis of endocytic vacuole formation and effect upon myogenesis in vitro","volume":"41","author":"Meirelles","year":"1986","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB26","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1128\/AAC.32.8.1237","article-title":"Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi","volume":"32","author":"Urbina","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1590\/S0074-02761992000200007","article-title":"Trypanosoma cruzi: effect of phenothiazines on the parasite and its interaction with host cells","volume":"87","author":"De Castro","year":"1992","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/jac\/41.2.197","article-title":"In vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi","volume":"41","author":"Liendo","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0166-6851(99)00129-2","article-title":"Sterol composition and biosynthesis in Trypanosoma cruzi amastigotes","volume":"104","author":"Liendo","year":"1999","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1126\/science.273.5277.969","article-title":"Cure of short- and long-term experimental Chagas disease using D0870","volume":"273","author":"Urbina","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB31","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.42.7.1771","article-title":"Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: In vitro and in vivo studies","volume":"42","author":"Urbina","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0006-2952(96)00903-3","article-title":"Altered lipid composition and enzyme activities of plasma membranes from Trypanosoma (Schizotrypanum) cruzi epimastigotes grown in the presence of sterol biosynthesis inhibitors","volume":"53","author":"Contreras","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0021-9673(01)85895-7","article-title":"Quantitative thin layer chromatography of lipids","volume":"27","author":"Cuzner","year":"1967","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0021-9258(19)67936-6","article-title":"The role of polyamines in the neutralization of deoxyribonucleic acid","volume":"235","author":"Ames","year":"1960","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB35","first-page":"559","article-title":"Myofibrillar breakdown and cytoskeletal alterations in heart muscle cells during invasion by Trypanosoma cruzi: immunological and ultrastructural study","volume":"25","author":"Pereira","year":"1993","journal-title":"J. Submicrosc. Cytol. Pathol."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/S0074-02761999000700015","article-title":"The reservosome of Trypanosoma cruzi epimastigotes: an organelle of the endocytic pathway with a role on metacyclogenesis","volume":"94","author":"Soares","year":"1999","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB37","unstructured":"Santa-Rita RM, Menna-Barreto RFS, De Castro SL. Studies with analogues of phospholipids against Trypanosoma cruzi and Leishmania amazonensis. In: Program and Abstracts of the Fifth COST-B9 Congress on Antiprotozoal Chemotherapy, London, 2002 [Abstract 25]."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0166-6851(81)90047-5","article-title":"Biochemical and ultrastructural alterations produced by miconazole and ketoconazole in Trypanosoma cruzi","volume":"3","author":"Docampo","year":"1981","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB39","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1128\/AAC.34.11.2097","article-title":"Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi","volume":"34","author":"Lazardi","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB40","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1128\/AAC.35.4.736","article-title":"Ultrastructural alterations induced by ICI 195,739, a bis triazole with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi","volume":"35","author":"Lazardi","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/AAC.46.2.487-499.2002","article-title":"Ultrastructural and biochemical alterations induced by 22,26-azasterol, a \u039424(25) sterol methyl transferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis","volume":"46","author":"Rodrigues","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1550-7408.1995.tb01591.x","article-title":"Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania","volume":"42","author":"Vannier-Santos","year":"1995","journal-title":"J. Eukaryotic Microbiol."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0924-8579(96)00325-1","article-title":"Ultrastructural alterations in Trypanosoma (Schizotrypanum) cruzi induced by \u039424(25) sterol methyl transferase inhibitors and their combinations with ketoconazole","volume":"7","author":"Vivas","year":"1996","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB44","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1550-7408.2001.tb00195.x","article-title":"The sterol composition of Trypanosoma cruzi changes after growth in different culture media and results in different sensitivity to digitonin-permeabilization","volume":"48","author":"Rodrigues","year":"2001","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB45","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1242\/jcs.111.5.597","article-title":"Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi","volume":"111","author":"Engel","year":"1998","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.pharmtox.38.1.375","article-title":"Mechanisms of action of bisphosphonates","volume":"38","author":"Rodan","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB47","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB48","doi-asserted-by":"crossref","first-page":"33609","DOI":"10.1074\/jbc.274.47.33609","article-title":"Trypanosoma cruzi contains major pyrophosphate stores, and its growth in vitro and in vivo is blocked by pyrophosphate analogues","volume":"274","author":"Urbina","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB49","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1083\/jcb.108.6.2355","article-title":"Polygons and adhesion plaques and disassembly and assembly of myofibrils in cardiac myocytes","volume":"108","author":"Lin","year":"1989","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ijantimicag.2003.07.020_BIB50","doi-asserted-by":"crossref","unstructured":"Garzoni LR, Caldera A, Meirelles MNL, de Castro SL, Docampo R, Meints GA, et al. Antiparasitic activity of risedronate in a murine model of acute Chagas disease. Int J Antimicrob Agents 2004;23:286\u201390.","DOI":"10.1016\/j.ijantimicag.2003.07.019"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903004060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903004060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T17:37:45Z","timestamp":1623692265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857903004060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0924857903004060"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2003.07.020","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}